Skandinaviska Enskilda Banken (SEB)
RNAM

Skandinaviska Enskilda Banken (SEB)’s Avidity Biosciences RNAM Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-44,000
Closed -$3.17M – 593
2025
Q4 		$3.17M Buy
+44,000
New +$2.84M 0.01% 495

Other funds holding RNAM

CC
Corsicana & Co Corsicana, Texas $206M AUM 26.42% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s RNAM Position: Q1 2026 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 44,000 shares — an estimated $3.17M sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in RNAM in Q4 2025 and held it in 1 quarter. The position peaked at $3.17M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 44,000 Avidity Biosciences shares in Q1 2026, an estimated $3.17M.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Avidity Biosciences in Q4 2025 and held it in 1 quarter.
  • Skandinaviska Enskilda Banken (SEB)'s Avidity Biosciences position peaked at $3.17M in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q1 2026, filed 15 May 2026.